Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis
Authors
Keywords
-
Journal
MEDICAL MICROBIOLOGY AND IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-01
DOI
10.1007/s00430-018-0570-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma
- (2018) Jinhyun Cho et al. ANNALS OF HEMATOLOGY
- Outlooks on Epstein-Barr virus associated gastric cancer
- (2018) Madiha Naseem et al. CANCER TREATMENT REVIEWS
- EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma
- (2018) Raymond W-M Lung et al. JOURNAL OF PATHOLOGY
- Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV
- (2018) Quentin Bazot et al. JOURNAL OF VIROLOGY
- Upregulation of the Chemokine Receptor CCR2B in Epstein‒Barr Virus-Positive Burkitt Lymphoma Cell Lines with the Latency III Program
- (2018) Svetlana Kozireva et al. Viruses-Basel
- Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome
- (2018) Agnieszka Szymula et al. PLoS Pathogens
- EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers
- (2018) Joanna Wilson et al. Cancers
- EBV MicroRNA BART16 Suppresses Type I IFN Signaling
- (2017) Marjolein J. G. Hooykaas et al. JOURNAL OF IMMUNOLOGY
- Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway
- (2017) Yuanjun Lu et al. Journal of Innate Immunity
- The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer
- (2017) Zhenzhen Zhao et al. JOURNAL OF MEDICAL VIROLOGY
- Epstein-Barr Virus LMP1-Mediated Oncogenicity
- (2017) Liang Wei Wang et al. JOURNAL OF VIROLOGY
- Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3
- (2017) Ryan Incrocci et al. VIROLOGY
- Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein-Barr virus-associated lymphomas
- (2016) Yang Zhang et al. JOURNAL OF MEDICAL VIROLOGY
- Consideration of Epstein-Barr Virus-Encoded Noncoding RNAs EBER1 and EBER2 as a Functional Backup of Viral Oncoprotein Latent Membrane Protein 1
- (2016) Kristina M. Herbert et al. mBio
- Lentivirus-mediated RNAi knockdown of LMP2A inhibits the growth of the Epstein-Barr-associated gastric carcinoma cell line GT38 in vitro
- (2016) Fangjun Wang et al. Experimental and Therapeutic Medicine
- An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation
- (2016) Sanket Kumar Shukla et al. Oncotarget
- EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation
- (2016) Yonggang Pei et al. PLoS Pathogens
- Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma
- (2016) Ling Zhou et al. MEDICAL SCIENCE MONITOR
- Post-transplant lymphoproliferative disorders
- (2016) Vikas R. Dharnidharka et al. Nature Reviews Disease Primers
- The tumor virus landscape of AIDS-related lymphomas
- (2015) A. Arvey et al. BLOOD
- BHRF1 exerts an antiapoptotic effect and cell cycle arrest via Bcl-2 in murine hybridomas
- (2015) Ernest Milián et al. JOURNAL OF BIOTECHNOLOGY
- Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells
- (2015) Laura R. Wasil et al. JOURNAL OF VIROLOGY
- Identification of MEF2B , EBF1 , and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival
- (2015) Italo Tempera et al. JOURNAL OF VIROLOGY
- EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis
- (2015) J Ma et al. LEUKEMIA
- Epstein–Barr Virus Infection and Gastric Cancer
- (2015) Xin-Zu Chen et al. MEDICINE
- The Epstein-Barr Virus Encoded BART miRNAs Potentiate Tumor Growth In Vivo
- (2015) Jin Qiu et al. PLoS Pathogens
- EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival
- (2015) Dong Kang et al. PLoS Pathogens
- Modulation of LMP2A Expression by a Newly Identified Epstein-Barr Virus-Encoded MicroRNA miR-BART22
- (2015) Raymond Wai-Ming Lung et al. NEOPLASIA
- The Epstein-Barr virus and the pathogenesis of lymphoma
- (2014) Martina Vockerodt et al. JOURNAL OF PATHOLOGY
- The role of Epstein-Barr virus in epithelial malignancies
- (2014) Sai-Wah Tsao et al. JOURNAL OF PATHOLOGY
- Role of the Immunoreceptor Tyrosine-Based Activation Motif of Latent Membrane Protein 2A (LMP2A) in Epstein-Barr Virus LMP2A-Induced Cell Transformation
- (2014) M. Fukuda et al. JOURNAL OF VIROLOGY
- Expression of latent membrane proteins in Epstein-Barr virus-transformed lymphocytes in vitro
- (2014) YUNLIAN TANG et al. Molecular Medicine Reports
- Epstein–Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1
- (2014) Quentin Bazot et al. NUCLEIC ACIDS RESEARCH
- Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy
- (2014) L Xiao et al. ONCOGENE
- Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line
- (2014) Charlotte Sueur et al. Virology Journal
- Epstein-Barr Virus Down-Regulates Tumor Suppressor DOK1 Expression
- (2014) Maha Siouda et al. PLoS Pathogens
- Epstein-Barr Virus Nuclear Antigen 3A Promotes Cellular Proliferation by Repression of the Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1
- (2014) Melissa L. Tursiella et al. PLoS Pathogens
- Epstein-Barr virus and nasopharyngeal carcinoma
- (2014) Lawrence S. Young et al. Chinese Journal of Cancer
- Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma
- (2013) K. Fish et al. BLOOD
- Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells
- (2013) Angela Kwok-Fung Lo et al. JOURNAL OF PATHOLOGY
- Autocrine CCL3 and CCL4 Induced by the Oncoprotein LMP1 Promote Epstein-Barr Virus-Triggered B Cell Proliferation
- (2013) S.-C. Tsai et al. JOURNAL OF VIROLOGY
- Nucleophosmin Contributes to the Transcriptional Activation Function of the Epstein-Barr Virus EBNA1 Protein
- (2013) N. Malik-Soni et al. JOURNAL OF VIROLOGY
- Epstein–Barr virus maintains lymphomas via its miRNAs
- (2013) D T Vereide et al. ONCOGENE
- Epstein–Barr virus-encoded small non-coding RNAs induce cancer cell chemoresistance and migration
- (2013) Aditi Sengupta Banerjee et al. VIROLOGY
- Epstein–Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor
- (2013) Sushil Kumar Sahu et al. VIROLOGY
- Epstein-Barr virus LMP2A signaling in statu nascendi mimics a B cell antigen receptor-like activation signal
- (2012) Niklas Engels et al. Cell Communication and Signaling
- Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma
- (2012) Ting Lei et al. INTERNATIONAL JOURNAL OF CANCER
- EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
- (2012) Robert E. White et al. JOURNAL OF CLINICAL INVESTIGATION
- E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions
- (2012) C. Borestrom et al. JOURNAL OF GENERAL VIROLOGY
- Epstein-Barr Virus Latent Membrane Protein-2A Induces ITAM/Syk- and Akt-Dependent Epithelial Migration through V-Integrin Membrane Translocation
- (2012) J. A. Fotheringham et al. JOURNAL OF VIROLOGY
- Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblasts
- (2012) Yongming Dai et al. Virology Journal
- E2F1 Mediated Apoptosis Induced by the DNA Damage Response Is Blocked by EBV Nuclear Antigen 3C in Lymphoblastoid Cells
- (2012) Abhik Saha et al. PLoS Pathogens
- Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs
- (2011) Alissa Michelle Go Wong et al. CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The molecular pathogenesis of Hodgkin lymphoma
- (2011) Katrina Farrell et al. HISTOPATHOLOGY
- Epstein-Barr Virus BamHI W Repeat Number Limits EBNA2/EBNA-LP Coexpression in Newly Infected B Cells and the Efficiency of B-Cell Transformation: a Rationale for the Multiple W Repeats in Wild-Type Virus Strains
- (2011) R. J. Tierney et al. JOURNAL OF VIROLOGY
- Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4Aand p14ARFexpression
- (2011) Seiji Maruo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Viral microRNA Cluster Strongly Potentiates the Transforming Properties of a Human Herpesvirus
- (2011) Regina Feederle et al. PLoS Pathogens
- Translating DNA damage into cancer cell death—A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance
- (2010) David Engelmann et al. DRUG RESISTANCE UPDATES
- EBNA3C Attenuates the Function of p53 through Interaction with Inhibitor of Growth Family Proteins 4 and 5
- (2010) A. Saha et al. JOURNAL OF VIROLOGY
- The dual PI3K/mTOR inhibitor, NVP-BEZ235, is efficacious against follicular lymphoma
- (2010) P M Bhende et al. LEUKEMIA
- Epigenetic Repression of p16INK4A by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP
- (2010) Lenka Skalska et al. PLoS Pathogens
- Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-κB pathway and promotes lymphomagenesis
- (2008) Cornelia Hömig-Hölzel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Epstein-Barr Virus Nuclear Antigen 3C Interacts with and Enhances the Stability of the c-Myc Oncoprotein
- (2008) B. G. Bajaj et al. JOURNAL OF VIROLOGY
- Interleukin-21 regulates expression of key Epstein–Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells
- (2008) Danijela Konforte et al. VIROLOGY
- The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein–Barr virus
- (2007) Helmut Kutz et al. VIROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started